About Hemarus Therapeutics Limited
Data last updated: 10 January 2026
Hemarus Therapeutics Limited is a public limited company based in Shaikpet, Telangana, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 16 September 2003, the company has been in operation for over 23 years.
Registered with ROC Hyderabad under CIN U74220AP2003PTC041698.
Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹10 Lakh. Formerly known as Hemarus Therapeutics Private Limited and Credence Clinical Research Private Limited. It is led by directors including Kavali Dharmendra and Balaraju Jittaboina.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shaikpet, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹900, a growth of 0% compared to the previous year.
The company has a workforce of approximately 68 employees as per the latest available data.
The company is associated with 1 brand - Hemarus. As per MCA filings, the company has satisfied charges of ₹75.4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemarus.co.in.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered Address8 – 2 – 293/82/Jiii/359, Plot No.359 – Iii Raod No.80 Jubilee Hills, Shaikpet, Telangana, India – 500033
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Hemarus Therapeutics Limited
Hemarus Therapeutics Limited has undergone 2 name changes throughout its history. The company was previously known as Hemarus Therapeutics Private Limited, and Credence Clinical Research Private Limited. The current legal name is Hemarus Therapeutics Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Hemarus Therapeutics Limited | Current |
| Hemarus Therapeutics Private Limited | Previous |
| Credence Clinical Research Private Limited | Previous |
CIN History of Hemarus Therapeutics Limited
Hemarus Therapeutics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74220TG2003PLC041698, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74220TG2003PLC041698 | Current |
| U74220AP2003PTC041698 | Previous |
| U74220AP2003PLC041698 | Previous |
Associated Brands with Hemarus Therapeutics Limited
Hemarus Therapeutics Limited operates one associated brand: Hemarus. These brands represent Hemarus Therapeutics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Specialty plasma derived biopharmaceuticals for bleeding disorders | hemarus.co.in |
Competitors & Alternatives of Hemarus Therapeutics Limited
Brands and companies operating in the same space as Hemarus Therapeutics Limited include GBT, Editas Medicine, Kedrion and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
GBT
|
Small molecules are developed for sickle cell disease treatment. | San Francisco, United States, United States | 2011 |
Editas Medicine
|
Therapeutics for rare genetic diseases are developed using CRISPR technology. | Cambridge, United States, United States | 2013 |
Kedrion
|
Plasma-derived therapies are developed for hemophilia and immune deficiencies. | Barga, Italy, Italy | 2001 |
Emmaus Medical
|
Emmaus Medical is engaged in developing treatments for rare diseases. | Torrance, United States, United States | 2000 |
LogicBio
|
Viral vectors are developed for genetic and infectious disease treatments. | Lexington, United States, United States | 2013 |
Modus Therapeutics
|
Polysaccharide-based drug for Sickle Cell Disease treatment is developed. | Stockholm, Sweden, Sweden | 2011 |
Cyclerion
|
Therapies for sickle cell disease and diabetic nephropathy are developed. | Cambridge, United States, United States | 2018 |
Business Activity of Hemarus Therapeutics Limited
Hemarus Therapeutics Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Hemarus Therapeutics Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Hemarus Therapeutics Limited
Hemarus Therapeutics Limited is currently managed by 3 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Kavali Dharmendra
Also directs:
Annapurnavijaya Bio Nutrients Llp, Lifestyle Industries Llp, Tavuk Farms Llp and 1 more
|
Director | 25 Oct 2024 | 1 Years 9 Months | Current |
| Balaraju Jittaboina | Director | 25 Oct 2024 | 1 Years 9 Months | Current |
| Santosh Kumar Surana | Director | 25 Oct 2024 | 1 Years 9 Months | Current |
Financials of Hemarus Therapeutics Limited FY 2025 filings available
Hemarus Therapeutics Limited reported revenue of ₹900 for FY 2025.
Ten-year financial statements for Hemarus Therapeutics Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hemarus Therapeutics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2011 | Indian Overseas Bank | ₹66.68 Cr | Satisfied |
| 10 Aug 2004 | Andhra Pradesh State Financial Corporation | ₹8.72 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Hemarus Therapeutics Limited
View historical data on people associated with Hemarus Therapeutics Limited, including employment history and EPFO contributions.
Employee and EPFO history for Hemarus Therapeutics Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Hemarus Therapeutics Limited
GST registrations and filing compliance for Hemarus Therapeutics Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Hemarus Therapeutics Limited
Credit ratings, litigation, and regulatory alerts for Hemarus Therapeutics Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hemarus Therapeutics Limited
MSME payment history for Hemarus Therapeutics Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hemarus Therapeutics Limited
Corporate group structure for Hemarus Therapeutics Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hemarus Therapeutics Limited
MCA filings and documents for Hemarus Therapeutics Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Hemarus Therapeutics Limited
Recent News on Hemarus Therapeutics Limited
Frequently Asked Questions about Hemarus Therapeutics Limited
Hemarus Therapeutics Limited is an active public limited company in the life sciences sector based in Shaikpet, Telangana, India. It was incorporated on 16 September 2003 (23+ years old) and is registered under CIN U74220TG2003PLC041698. The company has 68 employees.
Hemarus Therapeutics Limited reported revenue of ₹900 for FY 2025 (up 0.00% YoY).
The current directors of Hemarus Therapeutics Limited are:
- Kavali Dharmendra - Director
- Balaraju Jittaboina - Director
- Santosh Kumar Surana - Director
The primary industry of Hemarus Therapeutics Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Hemarus Therapeutics Limited can be reached at the registered office: 8 – 2 – 29382Jiii359, Plot No.359 – Iii Raod No.80 Jubilee Hills, Shaikpet, Telangana, India – 500033, or through the website hemarus.co.in.
The authorised capital is ₹40 Cr, and the paid-up capital is ₹10 Lakh.